Finding. Djp1, the Hsp40 that walks precursors from the ER surface to mitochondria, has a named lipid-enzyme client: Psd1, the inner-membrane phosphatidylserine decarboxylase that makes mitochondrial phosphatidylethanolamine. The help needs Psd1’s targeting signal and is not a generic Hsp40 or ER-targeting favor. Delete Djp1 and Psd1 together and cells get sicker than either single loss explains. Djp1 is also in phospholipid metabolism by another door.
Why this paper matters
Mitochondrial phospholipids are not a side quest. Lose them and you get disease-class organelle failure. The enzymes that make them are nuclear-encoded and imported. A targeting factor that is also a lipid-metabolism factor collapses two textbooks into one protein.
ER-SURF was a routing story. This paper makes it a PE story, then refuses to stop at Psd1. The synthetic-sick residual is the honest part: Djp1 is multifunctional, and Psd1 does not exhaust it.
What they actually measured
Biochemistry, proteomics, TLC. Psd1 regulation, targeting-signal dependence, Hsp40/ER-factor specificity. djp1 psd1 synthetic sickness interpreted as Psd1-independent phospholipid roles.
The abstract does not name the extra lipids or the organism. Yeast phospholipid genetics is the natural home. Wait for the chromatograms.
How to read the score
Around 80. A specific import client on a disease-relevant lipid enzyme, plus a second function. Confidence is medium. Score 80.
What to do with it
If you work on ER-SURF, PE, or mitochondrial import of inner-membrane enzymes, Djp1 belongs on the Psd1 biogenesis path. Pull the TLC and the double-mutant lipids. Do not call Djp1 a therapeutic target. The directional implication is that phospholipid identity and precursor routing share a cochaperone, twice.